4 listed pharma including Seoul Pharma spend more than 50% of their sales into SG&A

One of 3 listed pharmaceutical companies reportedly send 40% of their sales into selling, general and administrative(SG&A) expenses. Particularly, 4 companies, such as Seoul Pharma, Jin Yang Pharmaceutical, Korea Arlico Pharm and Dongkoo Bio&Pharma spent a half of their sales into the expenses.

In consideration of the fact that a regular industry spends about 20% of their sales into the expens...